XBI - XBI: The 2 Things Biotech Needs To Move Higher
2024-04-30 15:03:39 ET
Summary
- The biotech sector has experienced significant volatility but has returned around the same as the risk-free return from the 10-Year Treasury over the past year.
- There are two key items that will determine the direction of small and midcap biotech stocks in the months and quarters ahead.
- These are highlighted in the paragraphs below about SPDR® S&P Biotech ETF.
It has been a wild ride for investors in small and midcap biotech names over the past nine months. This can be seen in the chart around the SPDR® S&P Biotech ETF ( XBI ) below....
XBI: The 2 Things Biotech Needs To Move Higher